Abstract
One of the major problems of modern oncology drug is liver damage, requiring additional costs for its treatment. The aim of our work was to study medical and economic efficiency of various schemes of hepatoprotective treatment of toxic liver damage. The paper presents the use of pharmacoeconomic studies in the treatment of hepatic drug-induced hepatitis, which occurs after chemotherapy in patients with Hodgkin's lymphoma. The study was conducted in the two comparison groups on a "cost - effectiveness". This method was chosen because it is in effect depending on the process (method), treatment was varied, as well as costs incurred. The unit of the effect of the number of days required for the relief of hepatic failure has been selected. Economic analysis of the work includes not only toxic hepatitis therapy, and treatment of any disease complications such as hepatic encephalopathy. The study revealed that the effectiveness of therapy increased 1.4 times and the economic costs were 51.8 % reduced with hepatoprotective drug "remaxol".
Highlights
Экономические затраты при лечении лекарственного гепатита в онкологии являются весьма важной проблемой
The paper presents the use of pharmacoeconomic studies in the treatment of hepatic drug-induced hepatitis, which occurs after chemotherapy in patients with Hodgkin’s lymphoma
The study was conducted in the two comparison groups on a “cost – effectiveness”
Summary
Минздрава России, Иркутск, Россия 2 Иркутский авиационный завод – филиал ПАО «Корпорация «Иркут», Иркутск, Россия. Представлены данные фармакоэкономического исследования применения гепатопротекторов в лечении лекарственного гепатита, возникающего после проведения химиотерапии пациентам с лимфомой Ходжкина, показавшие увеличение эффекта от проводимой терапии в 1,4 раза и снижение экономических затрат на 51,8 %. The aim of our work was to study medical and economic efficiency of various schemes of hepatoprotective treatment of toxic liver damage. The study was conducted in the two comparison groups on a “cost – effectiveness” This method was chosen because it is in effect depending on the process (method), treatment was varied, as well as costs incurred. До настоящего времени применяемые с целью профилактики и лечения лекарственного поражения печени (ЛПП) гепатопротекторы, несмотря на их разнообразие (карсил, сирепар и др.), недостаточно эффективны.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.